Advancing Viral Safety with GMP-Validated NGS Frameworks
Having successfully elevated transcriptome-based analysis to full GMP standards with formal regulatory approval, establishing a robust platform for testing and characterizing allogeneic CAR-T therapies. By leveraging this proven methodology, we now offer specialized consultancy to guide your viral safety strategies using advanced NGS-based approaches for clinical applications.